Genitourinary Cancer and Trial Updates
The Genitourinary Cancer Channel on VJOncology is supported by Pfizer and Merck. The supporters have no influence over the production of the content.
Sacituzumab govitecan in metastatic urothelial carcinoma: updates on the Phase II study
Yohann Loriot • 23 Sep 2020
Updated analysis of KEYNOTE-426: pembro plus axitinib vs sunitinib in mRCC
Elizabeth Plimack • 1 Jun 2020